KALARIS THERAPEUTICS INC
KLRSNASDAQ🏆 #3452 by market capEarnings Nov 18US Equity
$3.97▲ $0.03 (+0.76%)
Market closed · at close1h—
24h▲ 0.8%
7d▼ 3.3%
14d▲ 17.1%
30d▼ 10.8%
1y▲ 58.2%
🏦Market Cap
$94M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
59
Weak
Earnings
Q3 · 2026Reported 2026-08-11Earnings Per Share
Actual
-0.48
Expected
-0.49
beat
+3.00%
YoY +21.30%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q3 2026
-0.48
beat
Q2 2026
-0.46
beat
Q1 2026
-0.44
beat
Q4 2025
-0.64
beat